Please login to the form below

Not currently logged in
Email:
Password:

pertuzumab

This page shows the latest pertuzumab news and features for those working in and with pharma, biotech and healthcare.

Daily Brief: Biosimilar Herceptin can't make Perjeta cost effective and more

Daily Brief: Biosimilar Herceptin can't make Perjeta cost effective and more

However NICE’s committee concluded that while biosimilar versions of intravenous trastuzumab will help to cut the cost of the adjuvant pertuzumab regimen, it still wasn’t enough to bring it ... of evidence on how long, if at all, adding pertuzumab

Latest news

More from news
Approximately 7 fully matching, plus 50 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Atlantis Healthcare

Atlantis Healthcare is a global leader in optimising patient self-management. Established in 1996, we design, develop and implement scalable solutions...

Latest intelligence

PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government
GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....

Infographics